BiotechTube
InnoRa

InnoRa

Berlin, Germany· Est.
innora.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

InnoRa is an established, privately-held German medtech firm with a core expertise in drug-device combination products, specifically drug-coated balloon catheters for vascular interventions. With over 23 years of experience and a significant patent portfolio, the company has transitioned from a developer to a revenue-generating commercial entity and service provider. Its business model combines the development and commercialization of its own proprietary DCB technology with client-focused contract development services for customized medical devices.

Cardiovascular DiseasesPeripheral Vascular Diseases

Technology Platform

Proprietary drug-coating platform for balloon catheters, enabling local delivery of anti-proliferative drugs to vascular lesions. Expertise spans formulation, coating processes, and catheter integration.

Opportunities

Growth in minimally invasive procedures for aging populations with cardiovascular disease expands the core DCB market.
The trend towards outsourcing complex R&D in medtech creates significant demand for their specialized contract development services.
Expansion into new vascular territories or combination therapies presents avenues for pipeline growth.

Risk Factors

Intense competition from large, integrated medtech companies with greater sales and marketing resources.
Regulatory scrutiny and evolving clinical data on the long-term safety of paclitaxel-coated devices in peripheral arteries could impact market dynamics.
Dependency on a core coating technology platform risks obsolescence if superior alternatives emerge.

Competitive Landscape

InnoRa competes in the drug-coated balloon segment against major players like Medtronic (IN.PACT), Boston Scientific (Ranger), BD (Intersect), and Philips (Stellarex). Its differentiation lies in its deep, specialized coating expertise and flexible partnership model, positioning it as a niche technology provider and service partner rather than a direct broad-scale commercial competitor to these giants.

More companies in Drug Delivery & Formulation →More companies in Germany →